All NASA markets
NAICS 541714 · Research and Development in Biotechnology (except Nanobiotechnology)

Top NASA research and development in biotechnology (except nanobiotechnology) contractors

In the 12 months ending Oct 5, 2026, the National Aeronautics and Space Administration obligated $22.3M in net prime contract dollars under NAICS 541714, up 44.0% from $15.5M in the preceding 12 months. 7 prime contractors received positive obligations, and 3 of them accounted for 80% of that spend.

Prime contracts funded by the National Aeronautics and Space Administration. Latest 12 months: Oct 6, 2025 to Oct 5, 2026. Source: USAspending.gov.

Net obligations, latest 12 months
$22.3M
up 44.0% vs. $15.5M
Prime contractors
7
With positive obligations
Top 8 primes’ share
100.0%
Of positive obligations
Awards with activity
23
19 in the prior 12 months

Obligations by fiscal year

Net prime contract obligations by federal fiscal year (October to September).

FY2022
$3.8M
FY2023
$2.8M
FY2024
$9.9M
FY2025
$15.5M
FY2026
$22.3M

Top NASA contractors for NAICS 541714

Ranked by positive obligations in the latest 12 months. Share is of all positive obligations in this market.

Top contractors, NASA NAICS 541714
#ContractorLatest 12 moPrior 12 moShareRank change
1STI Legacy, Inc.$11.8M$6.4M52.7%—
2Aspera Biomedicines, Inc.$4.3M$2.2M19.2%▲ 2
3National Stem Cell Foundation Inc.$2.8M$900K12.4%▲ 2
4Redwire Space Technologies, Inc.$2.2M$2.5M9.7%▼ 1
5Sierra Space Corp$1.2M$3.2M5.5%▼ 3
6Melanie Sauer & Associates LLC$55K$55K0.3%▲ 1
7Openteams Inc$25K$00.1%New

What changed in the last 12 months

Contractors with the largest change in reported obligations versus the preceding 12 months.

Largest gains

  • STI Legacy, Inc.
    $6.4M → $11.8M (+$5.3M) · now #1
  • Aspera Biomedicines, Inc.
    $2.2M → $4.3M (+$2.1M) · now #2
  • National Stem Cell Foundation Inc.
    $900K → $2.8M (+$1.9M) · now #3

Largest declines

  • Sierra Space Corp
    $3.2M → $1.2M (−$2.0M) · now #5
  • Redwire Space Technologies, Inc.
    $2.5M → $2.2M (−$330K) · now #4
  • Orbital Mining Corporation
    $150K → $0 (−$150K) · no latest-period obligations

New to this market

1 contractors received their first obligations in this market (since FY2022) during the latest 12 months. The largest:

New contractors
ContractorFirst obligationLatest 12 mo
Openteams IncJan 20, 2026$25K

Where the money comes from

Funding sub-agencies within the National Aeronautics and Space Administration, latest 12 months. The funding organization can differ from the office that runs the requirement.

Funding sub-agencies
Funding sub-agencyLatest 12 moPrior 12 moChange
National Aeronautics and Space Administration$22.3M$15.5MUp $6.8M (44.0%)

Potential recompetes

Large awards in this market whose current period of performance ends in the next 18 months. Treat these as research leads: options, extensions, and follow-on vehicles often change the timing.

Awards ending in the next 18 months
AwardIncumbentObligatedCurrent end
80JSC026FA027
STI Legacy, Inc.
PREPARE A FEASIBILITY ASSESSMENT OF LONG-TERM DEEP SPACE AVATAR RESEARCH OPPORTUNITIES. THESE EXPERIMENTS WILL UTILIZE AUTONOMOUS SYSTEMS ENABLING LONGER TERM SCIENCE OPERATIONS…
$3.4MOct 30, 2026
80JSC024FA073
STI Legacy, Inc.
A VIRTUAL ASTRONAUT TISSUE ANALOG RESPONSE (AVATAR) MISSIONS
$10.2MDec 31, 2026
80JSC023FA162
STI Legacy, Inc.
FOUR FULL SERVICE PAYLOAD INTERGRATION USES
$1.8MDec 31, 2026
80JSC025PA002
National Stem Cell Foundation Inc.
DESIGN, DEVELOPMENT, AND TESTING OF GROUND AND FLIGHT UNIT(S) AS WELL AS COMPLETION OF FLIGHT DEMONSTRATION(S) ON THE ISS NATIONAL LAB (NL) OR A CLD OR OTHER LEO ORBITAL PLATFORM.
$3.7MSep 30, 2027
80JSC026FA127
STI Legacy, Inc.
FEASIBILITY STUDY OF FLYING ORGANOIDS IN LEO USING THE SAME PAYLOAD MODEL AS FLOWN ON ARTEMIS II.
$2.8MDec 30, 2027
80JSC025PA001
Aspera Biomedicines, Inc.
RESEARCH AND DEVELOPMENT FOR IN-SPACE PRODUCTION CONCEPTS OF NANOBIOREACTOR MODELS. THIS WAS AWARDED OFF OF THE NASA RESEARCH ANNOUNCEMENT NNJ13ZBG001N. NOTE THAT "BASIC…
$6.5MFeb 15, 2028

Common questions

Who are the top NASA contractors for NAICS 541714?

In the latest 12 months, STI Legacy, Inc. ($11.8M), Aspera Biomedicines, Inc. ($4.3M), National Stem Cell Foundation Inc. ($2.8M) received the most NASA obligations for research and development in biotechnology (except nanobiotechnology).

How concentrated is this market?

The eight largest primes held 100.0% of positive obligations, and STI Legacy, Inc. alone held 52.7%. 1 contractors won their first obligations in this market during the latest 12 months.

Are any large NASA NAICS 541714 contracts ending soon?

6 of the largest awards in this market reach their current end date in the next 18 months. The first is 80JSC026FA027 (STI Legacy, Inc., $3.4M obligated), ending Oct 30, 2026. An end date is a research lead, not a confirmed recompete: options and extensions often move it.

Related markets

Figures are net obligations on prime contracts (award types A–D) from USAspending.gov, grouped by funding agency and the NAICS code on each award. Net obligations include deobligations and corrections, so they can differ from positive-obligation totals. See methodology.

Ready to win more?

Ready to connect your pursuit work?

GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.